Long‐term safety and efficacy of N8‐GP in previously treated adults and adolescents with hemophilia A: Final results from pathfinder2
Fiche du document
16 juin 2020
- doi: 10.1111/jth.14959
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1111/jth.14959
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32544297
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1538-7933
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1538-7836
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_FAE133F488349
info:eu-repo/semantics/openAccess , CC BY-NC 4.0 , https://creativecommons.org/licenses/by-nc/4.0/
Mots-clés
HematologySujets proches
Adolescents Teen-agers Young adults (Teenagers) Teens Haemophilia Hematophilia Classic hemophilia Factor VIII deficiency Hemophilia A Hemorrhagic diathesis Haematology Grown-ups Adults GrownupsCiter ce document
Paul Giangrande et al., « Long‐term safety and efficacy of N8‐GP in previously treated adults and adolescents with hemophilia A: Final results from pathfinder2 », Serveur académique Lausannois, ID : 10.1111/jth.14959
